Image quality and safety after iodixanol in intravenous urography. A comparison with iohexol

British Journal of Radiology

Volumn 69, Issue 824, 1996, Pages 699-703

  Sundgren, P C ^a   Baath L ^a   Tornquist C ^a   Hougens Grynne, B ^b   Kjaersgaard, P ^c   Almen T ^a  

^a LUND UNIVERSITY   (Sweden)

^b NYCOMED IMAGING AS   (Norway)

^c Medstat Research A/S   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; IODIXANOL; IOHEXOL; MONOMER;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; HUMAN; IMAGE QUALITY; INTRAVENOUS UROGRAPHY; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 0029835219     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/0007-1285-69-824-699     Document Type: Article

References (24)

1. NOSSEN, J O, AAKHUS, T, BERG, K J ET AL, Experience with iodixanol, a new non-ionic dimeric contrast medium. Preliminary results from the human Phase I study, Invest. Radiol., 25, S113-S114 (1990).
2. JORGENSEN, N P, NOSSEN, J O, BORCH, K W ET AL, Safety and tolerability of iodixanol in healthy volunteers with reference to two monomeric X-ray contrast media, Eur. J. Radiol., 15, 252-257 (1990).
3. SVALAND, M G, HAIDER, T, LANGSETH-MANRIQUE, K ET AL, Human pharmacokinetics of iodixanol, Invest. Radiol., 2, 130-133 (1992).
4. BOLSTAD, B, BORCH, K W, GRYNNE, B H ET AL, Safety and tolerability of iodixanol. A dimeric, nonionic contrast medium: An emphasis on European clinical phases I and II, Invest. Radiol., 26, S201-S204 (1991).
5. KLOW, N E, LEVORSTAD, K, BERG, K J ET AL, Iodixanol in cardioangiography in patients with coronary heart disease. Tolerability, cardiac and renal effects, Acta Radiol., 34, 72-77 (1993).
6. ALBRECHTSSON, V, LARUSDOTTIR, H, NORGREN, L and LUNDBY, B, Iodixanol - a new non-ionic dimer in aortofemoral angiography, Acta Radiol., 33, 11-13 (1992).
7. TVEIT, K, BOLZ, K-D, BOLSTAD, B ET AL, Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml, Acta Radiol., 35, 614-618 (1994).
8. CONROY, R M, BJARTVEIT, K, SHEPPICK, A ET AL, Iodixanol in intravenous urography: A comparison of iodixanol 270 mgI/ml, iodixanol 320 mgI/ml and iopamidol 300 mgI/ml (NIOPAM), Clin. Radiol., 49, 337-340 (1994).
9. GAVANT, M L and SIEGLE, R, Iodixanol in excretory urography: Initial clinical experience with a nonionic, dimeric (Ratio 6:1) contrast medium, Radiology, 183, 515-518 (1992).
10. FLINCK, A, SELIN, K and BJORNELD, L, Iodixanol in cardioangiography, Acta Radiol., 35 (Suppl. 394), 39 (1994).
11. SINGH, K, SUNDGREN, R, BOLSTAD, B ET AL, Iodixanol in abdominal digital subtraction angiography. A randomized, double-blind, parallel trial with iodixanol and iohexol, Acta Radiol, 34, 242-245 (1993).
12. PUGH, N D, SISSONS, G R J, RUTTLEY, M S T ET AL, Iodixanol in femoral arteriography (phase II) - a comparative double-blind parallel trial between iodixanol and iopromide, Clin. Radiol., 47, 96-99 (1993).
13. ASPELIN, P, NILSSON, P-E, SCHÖNBEIN, H S ET AL, Effect of four non-ionic contrast media on red blood cells in vitro. I Morphology, Acta Radiol. Suppl., 370, 79-83 (1987).
14. ASPELIN, P, NILSSON, P-E, SCHÖNBEIN, H S ET AL, Effect of four non-ionic contrast media on red blood cells in vitro. II Aggregation, Acta Radiol. Suppl., 370, 85-87 (1987).
15. ASPELIN, P, NILSSON, P-E, SCHÖNBEIN, H S ET AL, Effect of four non-ionic contrast media on red blood cells in vitro. III. Deformability, Acta Radiol. Suppl., 370, 89-91 (1987).
16. STORMORKEN, H and SAKARIASSEN, K S, Contrast media effects on haemostatic and thrombotic parameters. Possible consequences for practical techniques and prophylactic measures, Acta Radiol. Suppl., 399, 173-181 (1995).
17. GRABOWSKI, E F, JANG, I-K, GOLD, H ET AL, Platelet degranulation induced by some contrast media is independent of their nonionic vs ionic nature, Acta Radiol. Suppl., 399, 182-184 (1995).
18. JAKOBSEN, J Å, LUNDBY, B, KRISTOFFERSEN, D T ET AL, Evaluation of renal function with delayed CT after injection of nonionic monomeric and dimeric contrast media in healthy volunteers, Radiology, 182, 419-424 (1992).
19. MCLENNAN, B L, LING, D, RHOLL, K and JAMES, M, Urography with low osmolality contrast agents. Comparison of Hexabrix with Conray 325, Invest. Radiol., 21, 144-150 (1986).
20. AGRESTI, A, Categorical Data Analysis (John Wiley & Sons, New York) (1990).
21. BERRY, D A, Statistical Methodology in Pharmaceutical Sciences (Marcel Dekker, Inc., New York) (1990).
22. ALTMANN, D G, Practical Statistics for Medical Research (Chapman and Hall, London) (1991).
23. SPATARO, R F, FISCHER, H W and BOYLAN, L, Urography with low-osmolality contrast media. Comparative urinary excretion of iopamidol, hexabrix, and diatrizoate, Invest. Radiol., 17, 494-500 (1982).
24. SPATARO, R F, KATZBERG, R W, FISCHER, H W and MCMANNIS, M J, High-dose clinical urography with the low-osmolality contrast agent Hexabrix. Comparison with a conventional contrast agent, Radiology, 162, 9-14 (1987).